Donor-Patient Profile: Jack Wilson
Married since 1973, working in the same field since coming to Phoenix from New Jersey in 1975, and living in the only house he’d ever owned, Jack Wilson’s life was the picture of consistency. Then, in 1997, an oncologist informed him he had mantle cell lymphoma
An Intervention with Heart
Ovarian cancer is relatively rare, striking 1 out of 78 women. But it also is one of the deadliest cancers, with only 44 percent of patients surviving five years past their diagnosis. After their disease goes into remission, many patients worry the cancer will return.
A Shot at Prevention
Vaccines have helped transform our relationship with infectious diseases. In parts of the world with widespread vaccination, fatal illnesses like measles and whooping cough no longer inspire fear. Rather than fretting over microbes, most of us reading this magazine are more concerned about chronic diseases like diabetes, heart disease and cancer.
UA Researcher Studying New Treatment to Prolong Survival in Advanced Biliary Tract Cancers
A new treatment that may extend survival for patients with advanced biliary tract cancers — who typically face a grim outlook with average survival of less than a year — is being studied by a University of Arizona Cancer Center researcher. Biliary tract (liver, gallbladder and pancreas) cancers are a rare malignancy with only about 15,000 new cases in the United States each year, said Rachna Shroff, MD, section chief of gastrointestinal medical oncology and leader of the GI Disease-Oriented Team at the UA Cancer Center.
Joann Sweasy, PhD, Joins UA Cancer Center as Associate Director for Basic Sciences
Joann Sweasy, PhD, an expert in DNA repair and genomic instability, has joined the University of Arizona Cancer Center as associate director for basic sciences. Dr. Sweasy also has been appointed to a joint faculty position at the University of Arizona College of Medicine – Tucson in the Departments of Cellular and Molecular Medicine and Radiation Oncology.
Startup to Commercialize Blood Test for Most Major Cancers
When testing for such as lung cancer disease, doctors know that tissue biopsies are necessary and potentially life-saving, though the procedures used to gather tissue can lead to dangerous complications, from bleeding to lung collapse. To lower the need for invasive procedures, researchers at the University of Arizona developed a new blood test that can detect most major cancers and have launched a startup, DesertDx, to bring the invention to doctors and their patients.
Skin Cancer Chemoprevention
In every corner of our state, the sun beats down on towering saguaros, gangly roadrunners and dry river beds. The sun’s ultraviolet (UV) rays are the primary cause of skin cancer, and although they are hard to avoid in Arizona, many steps can be taken to reduce skin-cancer risk.
Novel Study Discovers ‘Metabolic Fingerprint’ to Help Treat, Diagnose and Prevent Cervical Cancer
Researchers at the University of Arizona have completed a first-of-its-kind study that could aid in the treatment, diagnosis and prevention of cervical cancer by identifying cervicovaginal metabolic signatures, or “fingerprints,” that distinguish patients with HPV, pre-cancerous cervical conditions and cancer.
What Is Chemoprevention?
Sherry Chow, PhD, devotes her career to chemoprevention, "a field that needs more attention."
Healing in Motion
Native Americans have the lowest five-year cancer survival rates of any U.S. population. Jennifer Bea, PhD, associate professor at the University of Arizona College of Medicine – Tucson, hopes to improve those statistics with Restoring Balance, a program tailored for a Native population that meets standards set by the American College of Sports Medicine (ACSM).